When was Mid Atlantic Bio Angels founded?

Mid Atlantic Bio Angels was founded in 2012.

Who is the founder of Mid Atlantic Bio Angels?

Yaniv Sneor and Stephen Goodman JD are the founders of Mid Atlantic Bio Angels.

Where is Mid Atlantic Bio Angels headquartered?

Mid Atlantic Bio Angels is headquartered in New York, NY.

How many investments has Mid Atlantic Bio Angels made?

Mid Atlantic Bio Angels has made 27 investments.

What has Mid Atlantic Bio Angels invested in?

Mid Atlantic Bio Angels has made numerous investments in companies like Astrocyte Pharma , Hilltop Bio , and Sonorous NV within the Drug Discovery, Commercial Products, and Devices and Supplies industries.

What has Mid Atlantic Bio Angels invested in recently?

Mid Atlantic Bio Angels's latest investment was on 18-Aug-2023 in Astrocyte Pharma , a company within the Drug Discovery industry.

Mid Atlantic Bio Angels Investor Profile: Portfolio & Exits

Mid Atlantic Bio Angels Overview

Investor Type

Angel Group

Status

Active

Professionals

1

Investments

27

Portfolio

16

Exits

5

Mid Atlantic Bio Angels General Information

Company Description

Founded in 2012, Mid Atlantic Bio Angels group is an angel group based in New York, New York. The firm seeks to invest in emerging life science firms.

Business Details

Website

www.bioangels.net

Year Founded

2012

Investor Status

Actively Seeking New Investments

Trade Association

Angel Capital Association (ACA)

Primary Investor Type

Angel Group

Corporate Office

145 East 27th Street
New York, NY 10016
United States





Mid Atlantic Bio Angels Investments (27)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Astrocyte Pharma	18-Aug-2023	Later Stage VC	Drug Discovery	Clinical Trials - Phase 1
Hilltop Bio	31-Mar-2023		Other Commercial Products	Generating Revenue
Sonorous NV	01-Jan-2023		Other Devices and Supplies	Pre-Clinical Trials
Seneca Therapeutics	22-Dec-2022		Drug Discovery	Clinical Trials - Phase 1
The Shape Sensing Company	10-Nov-2022		Fiberoptic Equipment	Generating Revenue
FEMSelect	22-Sep-2022		Surgical Devices	Generating Revenue
DeepLife	03-Aug-2022		Discovery Tools (Healthcare)	Generating Revenue
New View Surgical	01-Oct-2021		Surgical Devices	Generating Revenue
Astrocyte Pharma	30-Apr-2021	Later Stage VC	Drug Discovery	Clinical Trials - Phase 1
Healionics	16-Apr-2021	Later Stage VC	Therapeutic Devices	Clinical Trials - General

You’re viewing 10 of 27 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mid Atlantic Bio Angels Exits (5)

Company Name	Exit Date	Exit Type
Thermalin	12-May-2023	Out of Business
Cerus Endovascular	01-May-2023
Tarnhelm Therapeutics	01-Dec-2022
Salarius Pharmaceuticals	04-Jan-2019	Merger/Acquisition
Salarius Pharmaceuticals		Secondary Transaction - Open Market

To view Mid Atlantic Bio Angels’s complete exits history, request access »

Mid Atlantic Bio Angels Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.